Trial outcome by treatment group and core cluster
| Core cluster | Non-core cluster | Total | |
| n=548 | n=523 | n=1071 | |
| Treatment failure on or before day 4 | 33 (6.0%) | 26 (5.0%) | 59 (5.5%) |
| Amoxicillin group | 10 (3.6%) | 12 (4.5%) | 22 (4.1%) |
| Placebo group | 23 (8.5%) | 14 (5.4%) | 37 (7.0%) |
| Clinical relapse after day 4 | 23 (4.9%) | 36 (8.3%) | 59 (6.6%) |
| Amoxicillin group | 11 (4.5%) | 22 (10.0%) | 33 (7.1%) |
| Placebo group | 12 (5.4%) | 14 (6.6%) | 26 (6.0%) |
| Treatment failure or clinical relapse on or prior to day 14 | 56 (11.2%) | 62 (13.5%) | 118 (12.3%) |
| Amoxicillin group | 21 (8.3%) | 34 (14.6%) | 55 (11.3%) |
| Placebo group | 35 (14.2%) | 28 (12.4%) | 63 (13.3%) |